High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas

  • Authors:
    • Ming-Zhi Han
    • Bin Huang
    • An-Jing Chen
    • Xin Zhang
    • Ran Xu
    • Jian Wang
    • Xin-Gang Li
  • View Affiliations

  • Published online on: January 3, 2017     https://doi.org/10.3892/or.2017.5349
  • Pages: 903-912
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The Ras-related GTP-binding protein (RAB) family plays an important role in regulating signal transduction and cellular processes including vesicle transport, cytoskeleton formation and membrane trafficking. More recently, several RAB members have been reported to promote tumorigenesis in many types of cancers. However, the clinical significance and potential function of RAB43 in gliomas remain unclear. Herein, we found that RAB43 was upregulated and positively correlated with the grade of progression in glioma patients by in silico analysis and immunohistochemistry (IHC). Patients with high RAB43 displayed worse clinical outcomes in comparison to those with low RAB43. RAB43 was also highly expressed in mesenchymal and G3 subtypes, and isocitrate dehydrogenase 1 (IDH1) wild-type gliomas. Moreover, transcriptomic analyses via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways revealed that RAB43‑related gene sets were mainly involved in the regulation of cell adhesion and cell migration processes. Further investigation indicated that RAB43 downregulation significantly suppressed the migratory and invasive ability of glioma cells, as well as decreased the expression of epithelial-mesenchymal transition (EMT) markers (N-cadherin, vimentin and Snail). In conclusion, a high level of RAB43 was significantly associated with the malignant phenotypes of gliomas, which suggests that RAB43 may serve as a novel biomarker and a potential therapeutic target for gliomas.
View Figures
View References

Related Articles

Journal Cover

February-2017
Volume 37 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Han M, Huang B, Chen A, Zhang X, Xu R, Wang J and Li X: High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas. Oncol Rep 37: 903-912, 2017.
APA
Han, M., Huang, B., Chen, A., Zhang, X., Xu, R., Wang, J., & Li, X. (2017). High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas. Oncology Reports, 37, 903-912. https://doi.org/10.3892/or.2017.5349
MLA
Han, M., Huang, B., Chen, A., Zhang, X., Xu, R., Wang, J., Li, X."High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas". Oncology Reports 37.2 (2017): 903-912.
Chicago
Han, M., Huang, B., Chen, A., Zhang, X., Xu, R., Wang, J., Li, X."High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas". Oncology Reports 37, no. 2 (2017): 903-912. https://doi.org/10.3892/or.2017.5349